Other authors described, in an in vitro model, that activation of the Nrf2 pathway induced by SFN restored the defective phagocytic capacity of alveolar macrophages isolated from patients with chronic obstructive pulmonary disease. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.